ENTITY
Exelixis Inc

Exelixis Inc (EXEL US)

11
Analysis
Health CareUnited States
Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.
more
Refresh
Company Presentation07 Aug 2024 05:00
Company Presentation01 May 2024 05:00
Company Presentation07 Feb 2024 06:00
Company Presentation12 Dec 2023 22:00
Company Presentation02 Nov 2023 05:00
x